Archive for 2007/02


Statement On The Passing Of Congressman Charlie Norwood (R-GA), By John Kirkwood, American Lung Association President & CEO

The American Lung Association's volunteers and staff wish to express our deepest condolences to family of U.S. Congressman Charlie Norwood, DDS (R-GA), who died today after a long battle with idiopathic pulmonary fibrosis and lung cancer. A long-time champion for all patients, Representative Norwood inspired lung disease patients across the country when he returned to Congress following his lung transplant in 2004. [click link for full article]
(more...)


Ethiopians With TB Must Overcome Barriers To Complete Treatment

One in five Ethiopians treated for tuberculosis fails to complete the length course of drugs required, according to a study by Ethiopian and Norwegian researchers, published in PLoS Medicine. The research has made clear some of the difficulties that patients must overcome in order to succeed in completing a course of treatment. People who cannot easily travel to a treatment centre are the most likely to 'default'. [click link for full article]
(more...)


High Rates Of Latent TB Infection Found In Russian Health Workers

Testing for tuberculosis has revealed that nearly 40% of the doctors in one Russian city have latent infection, with even higher levels in those who work in TB clinics. The research has been published in PLoS Medicine.TB disease is a growing problem worldwide. Russia is one country where it is particularly common. Although up to a third of the world's population are infected with the bacterium that causes the disease, in most people the infection remains 'latent'. [click link for full article]
(more...)


Astrazeneca Launches A Smarter Approach To Asthma Management In Europe

AstraZeneca today announced that 37 countries to date have received approval of Symbicort® Maintenance And Reliever Therapy (Symbicort SMART®), and that a period of world wide launches will now be initiated. This new, smarter approach to asthma is the first to provide patients with both asthma maintenance and reliever therapy together in just one inhaler. [click link for full article]
(more...)


Thomson Medstat Survey Finds Over One-Third Of Americans Now Using Alternative Medicine

More than 37 percent of U.S. households regularly turn to alternative treatments for everything from headaches to diabetes, according to a survey conducted by Thomson Medstat, a business of The Thomson Corporation (TSX: TOC; NYSE: TOC). Thomson Medstat's 2006 consumer healthcare survey asked 23,000 adults about their use of alternative medicine and found that: -- 37.2 percent of U.S. households use some form of alternative medicine. [click link for full article]
(more...)


Medicsight Plc Receives Canadian Medical Device Licenses For ColonCAD API And LungCAD API

MGT Capital Investments, Inc. (Amex: MGT), an investment company focused on the health care information technology sector, announced today that its subsidiary, Medicsight plc, was granted medical device licenses from the Therapeutic Products Directorate (TPD) of Health Canada to begin marketing and selling Medicsight ColonCAD API and Medicsight LungCAD API. [click link for full article]
(more...)


Intense Cessation Treatment Proves Successful In High-Risk Smokers

Hospitalized patients who undergo structured treatment to quit smoking are significantly more likely to remain smoke-free, says a new study. New research published in the February issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), suggests that high-risk smokers with acute cardiovascular disease are three to four times more likely to quit smoking when treated with an intensive smoking cessation program. [click link for full article]
(more...)


Sanofi-Aventis Announces Update To U.S. Prescribing Information For Ketek(R) (Telithromycin)

Sanofi-aventis today announced that the U.S. Food and Drug Administration (FDA) has approved revisions to the US Prescribing Information for Ketek(R) (telithromycin). These revisions follow discussions with the FDA and are based on recommendations of a FDA Joint Advisory Committee meeting of the Drug Safety and Risk Management Advisory Committee and Anti-infective Drug Advisory Committee held in December 2006. [click link for full article]
(more...)


Slow-Release Morphine Reduces Level Of Intractable Cough

Slow-release morphine helped a group of patients with long-term, treatment-resistant chronic cough reduce their daily cough score levels by 40 percent. The research results appear in the second issue for February 2007 of the American Journal of Respiratory and Critical Care Medicine, published by the American Thoracic Society. Alyn H. Morice, M.D. [click link for full article]
(more...)


Drug Reduces Unscheduled Trips To Doctor For Childhood Asthma Attacks

Young children with attacks of sporadic, recurring asthma who were treated with the prescription drug montelukast by their parents had fewer unscheduled trips to the doctor, missed less days from school or childcare, and caused their parents to take fewer days off work for their care. Results from this multi-center, randomized, double-blind and placebo-controlled trial appear in the second issue for February 2007 of the [click link for full article]
(more...)